{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T10:40:37Z","timestamp":1710931237672},"reference-count":14,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2004,6,22]],"date-time":"2004-06-22T00:00:00Z","timestamp":1087862400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Deutsche Derma Gesell"],"published-print":{"date-parts":[[2004,7]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:p>Vier Fallberichte von Patienten mit myeloproliferativem Syndrom, die zur Therapie Hydroxycarbamid (Synonyme: Hydroxyurea, Hydroxyharnstoff; Handelsnamen: Litalir\u00ae, Syrea\u00ae) einnehmen, und bei denen es einige Monate nach Beginn der Therapie zum Auftreten stri\u00e4rer, longitudinaler Pigmentierungen der Finger\u2010 und Fu\u00dfn\u00e4gel kommt.<\/jats:p><jats:p> <jats:italic>Hintergrund:<\/jats:italic> Pigmentierungen von Finger\u2010 und Fu\u00dfn\u00e4geln er\u00f6ffnen ein weites Feld der Differentialdiagnosen. Sie k\u00f6nnen mikrobiologischer, melanozyt\u00e4rer, stoffwechselbedingter oder exogener Ursache sein.<\/jats:p><jats:p> <jats:italic>Patienten und Methodik:<\/jats:italic> Wir berichten \u00fcber drei weibliche und einen m\u00e4nnlichen Patienten im Alter zwischen 62 und 87\u2005Jahren mit myeloproliferativem Syndrom oder chronisch myeloischer Leuk\u00e4mie, die zur Behandlung \u00fcber f\u00fcnf bis zw\u00f6lf Jahre Hydroxycarbamid Synonyme: Hydroxyurea, Hydroxyharnstoff; Handelsnamen: Litalir\u00ae, Syrea\u00ae) einnahmen oder noch einnehmen. Die vier Patienten haben einen Hauttyp\u2005II nach Fitzpatrick.<\/jats:p><jats:p> <jats:italic>Ergebnisse:<\/jats:italic> Mehrere Monate nach Beginn der Einnahme kam es zu stri\u00e4ren, longitudinalen Pigmentierungen an Finger\u2010 und Fu\u00dfn\u00e4geln. Bei zwei Patienten wurde dieser Befund als Zufallsbefund diagnostiziert, w\u00e4hrend sich die anderen beiden Patienten wegen der Nagelpigmentierungen in hautfach\u00e4rztliche Behandlung begaben.<\/jats:p><jats:p>Bei zwei der Patienten kam es wenige Monate nach Absetzen von Hydroxycarbamid zum Verschwinden der longitudinalen Pigmentierung w\u00e4hrend bei einem Patienten die Melanonychie der Finger\u2010 und Fu\u00dfn\u00e4gel bestehen blieb. Eine Patientin konnte wegen fehlenden Kontaktes nicht nachkontrolliert werden.<\/jats:p><jats:p> <jats:italic>Schlu\u00dffolgerung:<\/jats:italic> Beim Auftreten longitudinaler Melanonychie bei h\u00e4mato\u2010onkologischen Patienten ist eine genaue Anamnese, insbesondere bez\u00fcglich der Medikamente wichtig, da durch Hydroxyharnstoff Pigmentierungen der Finger\u2010 und Fu\u00dfn\u00e4gel auftreten k\u00f6nnen. Nach wie vor m\u00fcssen jegliche melanozyt\u00e4re Pigmentierungen der Akren, die Ausdruck eines akrolentigin\u00f6sen Melanoms sein k\u00f6nnen, diagnostisch ausgeschlossen werden.<\/jats:p>","DOI":"10.1046\/j.1439-0353.2004.04093.x","type":"journal-article","created":{"date-parts":[[2004,6,22]],"date-time":"2004-06-22T13:35:07Z","timestamp":1087911307000},"page":"588-591","source":"Crossref","is-referenced-by-count":11,"title":["Longitudinale Melanonychie bei Einnahme von Hydroxycarbamid"],"prefix":"10.1111","volume":"2","author":[{"given":"Sven","family":"Neynaber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerd","family":"Plewig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"Wienecke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,6,22]]},"reference":[{"key":"e_1_2_4_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2001.01916.x"},{"key":"e_1_2_4_3_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2001-13799"},{"key":"e_1_2_4_4_2","first-page":"491","article-title":"Melanosis often not black: melanotic whitlow","volume":"1","author":"Hutchinson J","year":"1886","journal-title":"Br J Med"},{"key":"e_1_2_4_5_2","first-page":"512","article-title":"Laugier\u2010Hunziker\u2010Baran\u2010Syndrom","volume":"42","author":"Haneke E","year":"1991","journal-title":"Hautarzt"},{"key":"e_1_2_4_6_2","first-page":"217","article-title":"Hydroxyurea and lower leg ulcers","volume":"52","author":"Nguyen TV","year":"1993","journal-title":"Cutis"},{"key":"e_1_2_4_7_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.120910"},{"key":"e_1_2_4_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.2000.00988-2.x"},{"key":"e_1_2_4_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0248-8663(00)87226-4"},{"key":"e_1_2_4_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(89)70324-8"},{"key":"e_1_2_4_11_2","unstructured":"BaranR DawberRPR. Diseases of the nails and their management 2nd edition Blackwell Oxford 1994."},{"key":"e_1_2_4_12_2","first-page":"205","article-title":"Longitudinal melanonychia induced by hydroxyurea: four case reports and review of the literature","volume":"37","author":"Delmas\u2010Marsalet B","year":"1995","journal-title":"Nouv Rev Fr Hematol"},{"key":"e_1_2_4_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(99)70379-8"},{"key":"e_1_2_4_14_2","doi-asserted-by":"crossref","unstructured":"WieneckeR MesserG WolffH. Longitudinale Melanonychie bei Einnahme von Hydroxyharnstoff. In: Plewig G Wolff H: Fortschritte der praktischen Dermatologie und Venerologie. Heidelberg: Springer 1998; 655\u200a\u2013\u200a656.","DOI":"10.1007\/978-3-662-01058-7_100"},{"key":"e_1_2_4_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.1986.tb01450.x"}],"container-title":["JDDG: Journal der Deutschen Dermatologischen Gesellschaft"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1439-0353.2004.04093.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1439-0353.2004.04093.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T16:32:24Z","timestamp":1697214744000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1439-0353.2004.04093.x"}},"subtitle":["Longitudinal melanonychia induced by hydroxyurea therapy"],"short-title":[],"issued":{"date-parts":[[2004,6,22]]},"references-count":14,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["10.1046\/j.1439-0353.2004.04093.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1439-0353.2004.04093.x","archive":["Portico"],"relation":{},"ISSN":["1610-0379","1610-0387"],"issn-type":[{"value":"1610-0379","type":"print"},{"value":"1610-0387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,6,22]]}}}